期刊文献+

肺癌中IMP3的表达及其临床病理意义 被引量:2

Expression of IMP3 in lung cancer and its clinicopathological significance
下载PDF
导出
摘要 目的探讨胰岛素样生长因子ⅡmRNA结合蛋白3(insulin-like growth factor II mRNA-binding protein 3,IMP3)在肺癌中的表达及其临床病理意义。方法采用免疫组化和荧光定量PCR法检测178例肺癌组织中IMP3蛋白及mRNA的表达,分析其表达与肺癌临床病理特征及预后的关系。结果与癌旁组织相比,肺癌组织中IMP3蛋白及mRNA表达水平均显著上调(P<0.01)。IMP3蛋白表达水平与患者性别、病理类型、病理学分期、血清CEA水平有关(P<0.05)。Kaplan-Meier单因素分析显示IMP3表达、淋巴结转移、病理学分期与患者的疾病无进展生存期(progression-free survival,PFS)有关,淋巴结转移、吸烟与总生存期(overall survival,OS)有关(P<0.05)。Cox多因素分析显示IMP3表达、淋巴结转移、肿瘤直径是PFS的独立影响因素;病理学分期是OS的独立影响因素(P<0.05)。结论IMP3表达与肺癌的发生、发展密切相关,是肺癌患者疾病进展的独立预测因子。 Purpose To investigate the expression and clinicopathological significance of insulin-like growth factor II mRNA-binding protein 3(IMP3)in lung cancer.Methods Immunohistochemistry and fluorescent quantitative PCR were used to detect the expression of IMP3 protein and mRNA in 178 patients of lung cancer.The relationships between IMP3 expression and clinicopathological characteristics,as well as clinical prognosis were analyzed.Results Compared with adjacent tissues,the expression levels of IMP3 protein and mRNA in lung cancer tissues were significantly up-regulated(P<0.01).The expression of IMP3 was related to gender,pathological type,pathological stage and serum CEA level of the patients(P<0.05).Kaplan-Meier univariate analysis suggested that IMP3 expression,lymph node metastasis,pathological stage were associated with progression-free survival(PFS),while lymph node metastasis and smoke were associated with overall survival(OS)(P<0.05).Cox multivariate analysis suggested that IMP3 expression,lymph node metastasis,and tumor size were independent factors influencing PFS,while pathological stage was an independent risk factor associated with OS(P<0.05).Conclusion The expression of IMP3 is closely related to the occurrence and development of lung cancer.It is an independent predictor of disease progression in lung cancer patients.
作者 姚梅宏 杨映红 黄建平 冯昌银 连渊娥 YAO Mei-hong;YANG Ying-hong;HUANG Jian-ping;FENG Chang-yin;LIAN Yuan-e(Department of Pathology,Fujian Medical University Union Hospital,Fuzhou 350001,China)
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2019年第12期1407-1411,1417,共6页 Chinese Journal of Clinical and Experimental Pathology
关键词 肺肿瘤 IMP3 荧光定量PCR 免疫组织化学 临床预后 lung neoplasms IMP3 fluorescent quantitative PCR immunohistochemistry clinical prognosis
  • 相关文献

参考文献6

二级参考文献47

  • 1于冬梅,阎晓初,郭德玉,柳凤轩,刘丽梅.VEGF和nm23蛋白在膀胱移行细胞癌中表达及临床意义[J].第三军医大学学报,2006,28(21):2180-2182. 被引量:16
  • 2黄文斌(摘译.IMP3是宫颈原位腺癌一个新的标记物[J].临床与实验病理学杂志,2007,23(4):411-411. 被引量:24
  • 3Foulstone E, Prince S, Zaccheo O, et al. Insulin-like growth fac- tor ligands, receptors, and binding proteins in cancer[J].J pathol, 2005,205 (2) : 145-153.
  • 4Findeis-Hosey JJ, Xu H. The use of insulin like-growth factor 1I messenger RNA binding protein-3 in diagnostic pathology[ J]. Hum Patho1,2011,42(3 ) :303-314.
  • 5Findeis-I-Iosey J J, Yang Q, Spaulding BO, et al. IMP3 expression is correlated with histologic grade of lung adenocarcinoma [ J ]. Hum pathol ,2010 ,41 (4) :477-484.
  • 6Ikenberg K, Fritzsche FR, Zuerrer-haerdi U, et al. Insulin-like growth factor II mRNA binding protein 3 ( IMP3 ) is overexpressed in prostate cancer and correlates with higher Gleason score [ J ]. BMC Cancer,2010,10(6) :341.
  • 7Pryor JG, Bourne PA, Yang Q, et al. IMP-3 is a novel progres- sion marker in malignant melanoma [ J ]. Mod Pathol, 2008,21 (4) :431-437.
  • 8Liao B, Hu Y, Herrick DJ, et al. The RNA-binding protein IMP- 3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K542 leukemia cells [ J ]. J Boil Chem,2005,280(18) :18517-18524.
  • 9彭凤兰.胰岛素样生长因子2(Igf2)研究进展[J].实用预防医学,2007,14(6):1963-1966. 被引量:7
  • 10Tezcan G, Tunca B, Bekar A, et al. microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells[J]. Cell Mol Neurobiol, 2014, 34(5):679-692.

共引文献24

同被引文献28

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部